chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Papular, erythematous rash to cheeks, neck, upper anterior torso with some petichiae that started about 6 hours after vaccine administration and lasted until about 5 days after administration
Patient began to cough, then had trouble breathing after about 2 hrs within next 1 hr pt got nausea, lightheadedness, dizziness, itchy throat, after 8 hrs symptoms got better but pt went to doctor, gave BENADRYL. Pt was fine-symptoms resolved.
Morning of 1/24/21 (Sunday), patient saw that the right side of her face was drooping, her right eye was swollen and excessively tearing.  Patient noted drooling out of the right side of mouth when drinking fluids or eating food.  Patient was unable to chew on the right side, had difficulty speaking due to the drooping of the right side of her mouth. Symptoms persisted into the next day. Patient was seen by her PCP and was diagnosed with Facial Palsy (Bell's Palsy). Patient's neurological assessment was negative for stroke symptoms.
no adverse event; patient got their first dose of GARDASIL 9 at age 18 (dose given 18Dec2020) and then did not get their second dose until 8 months later (dose given 31Aug2021); This spontaneous report was received from a pharmacist, concerning a 19-year-old male patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, and previous drug reactions or allergies.  On 18-DEC-2020 reported as "when the patient was 18 years old", he was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration, anatomical location, lot number and expiration date were not reported), as prophylaxis. On 31-AUG-2021 reported as "8 months later", he received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration, anatomical location, lot number and expiration date were not reported), as prophylaxis (inappropriate schedule of product administration). On 10-JAN-2022 reported as "today", the patient was at the pharmacy to receive the third dose. No further adverse events were reported.
Patient experienced a few seconds of syncope while sitting down a few minutes after receiving first dose of pfizer vaccine. He regained consciousness quickly and was directed to lay down flat on his back with his legs in the air. Patient immediately felt better, remained in this position for 25 minutes and left the pharmacy after 35 minutes feeling well.
ears plugged, low temp , loss of taste, post nasal drainage, sinus congestion.        Patient denies headache, sore throat, shortness of breath, body aches, diarrhea, loss of smell, cough. starting 12/3/21
Rash 2 weeks after COVID Vaccine  Symptoms: RASH&OTH NONSPEC SKIN ERUPTION.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 31 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Stone fruits" (unspecified if ongoing); "Depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset Jun2022, outcome "unknown", COVID-19 (medically significant) with onset Jun2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
CHILLS; SORE ARM; This spontaneous report received from a consumer concerned an 80 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 29-JAN-2022 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JAN-2022, the patient experienced chills, and sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and sore arm was not reported. This report was non-serious.
I had typical flu-like symptoms the day after my vaccine. It cleared up a few days later. About a week after getting my vaccine and ongoing, I started having a flare up of my auto immune disease (Crohn's) that was in remission for 10 years. I was nauseous, stomaching pains, typical symptoms of Crohn's. In May my doctor prescribed medication to help with my Crohn's but those were not helping my flare up so I ended up going to the hospital for four days. The second week of June I went back to the hospital again for three days. In the hospital I was given steroids and antibiotics.
2 1/2 wks p/1st MMR experienced bilateral wrist, finger & knee joint swelling, stiffness, aching; Also mild URI sx;
Left side of my face and entire tongue got pins & needles feeling about 17 minutes after shot. was given a shot of Benadryl. For the next 4 days the sensation would repeat and I controlled it with Benadryl. My neck and face were swollen. The sensation also spread to left arm in the following days.  Starting 4/7/21, the pins and needles feeling has returned to my left face. The swelling has never completely gone down on the left side of my face. The tingling is worse today and my body is itching.
I am actually not certain which COVID  vaccine she got but she came to our hospital having a stroke confirmed by CT
p/vax pt devel hard itchy lump where vax was given; got bigger & itchier; also migraine
bilateral eye deviation to the left; moaning; Muscle tightness; Staring; Unresponsive to stimuli; This non-serious case was received during the monitoring on 11-APR-2022 with the following Primary ID 2204963-1. The original narrative from the sender is as below:  Infant received routine vaccines at 6 week well check. Within 12 hours of vaccination, had one episode where baby moaned then turned head to the left, become very tight, accompanied by bilateral eye deviation to the left, staring off unresponsive to sound or movement. No generalized convulsion. Episode lasted 1-1.5 minutes. No repeat episodes.  Current illness included Hyperbilirubinemia requiring phototherapy.  Medications at time of vaccination included Polyvisol with Iron oral drops.  Lab data none, history none and allergies none.
Rash all over body and is spreading. Started with just hands and feet, now everywhere.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Feb2021 at 14:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not report any relevant medical history. Concomitant medications included sertraline hydrochloride (ZOLOFT) for unknown indication and since an unknown date. The patient did not have any allergies to medication, food or any other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Mar2021, the patient experienced rash all over body. The patient reported that the arm where the injection was given was perfectly fine and the rash was spreading. It started with just hands and feet, then everywhere. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19.  On an unknown date in 2021, the patient underwent COVID-19 test and the result was negative. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event rash all over the body was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Reported Left arm swelling and Left arm tingling. Subjective  Narrative:  During vaccine clinic visit, the employee was monitored. Was provided cetirizine and symptoms resolved within 30 minutes
Lingering shoulder pain, unable to lift my arm without severe pain that has been getting progressively worse.
Epiglottis; Developed tightness in my throat; Chills; Muscle aches; This is a spontaneous report from a contactable consumer. A female patient 60 years old female received BNT162B2 (PFIZER-BIONTECH COVID-VACCINE, Formulation was Solution for injection, Lot Number: EW0180), dose 2 via intramuscular in left arm on 08-Jul2021 11:30, DOSE 2, SINGLE as single dose for COVID-19 immunization. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient medical history and concomitant medications were not reported. The patient previously took first dose BNT162B2 (PFIZER-BIONTECH COVID-VACCINE, Formulation was Solution for injection, Lot Number: EW0180), dose 2 via an unspecified route on 17Jun2021 01:30, DOSE 1, SINGLE as single dose for COVID-19 immunization. On 10Jul2021 04:00 AM patient developed tightness in her throat, and it felt like her airway on the right side was closing. This was after developing chills and muscle aches that began early on Friday morning, approximately 15 hours after her second Pfizer shot. She went to the emergency room and was diagnosed with epiglottis. She received two shots of epinephrine, an IV and CT scan and prescribed antibiotics, a steroid and antihistamine. She had only mild side effects after the 1st shot sore arm after the first shot. Patient was allergic to penicillin only. The outcome of all events were recovering.  Information on the lot/batch number has been requested.  Follow-Up (19Jul2021): Follow-up attempts are completed. No further information is expected.
Welt at injection site; Bigger spot of redness; Felt tired; Red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Welt at injection site), ERYTHEMA (Bigger spot of redness), INJECTION SITE ERYTHEMA (Red at injection site) and FATIGUE (Felt tired) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1414) for an unknown indication.     The patient's past medical history included No adverse event (No historical condition was reported.).    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Red at injection site). On 23-Feb-2021, the patient experienced URTICARIA (Welt at injection site), ERYTHEMA (Bigger spot of redness) and FATIGUE (Felt tired). At the time of the report, URTICARIA (Welt at injection site), ERYTHEMA (Bigger spot of redness), INJECTION SITE ERYTHEMA (Red at injection site) and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
First dose:   Shingles appeared on upper chest on evening of injection.  Burned,  painful if fabric or anything touched area.  Pain lasted till next AM but evidence of rash lasted a couple weeks.  Second dose:  shingles appeared in same area as before (upper chest) but also on neck & face.  Burned. Painful if fabric or anything touched area.  Chills at night.  Next AM:   Face & eyes swollen.  By noon, day after injection,  area still red but not as painful. Swelling in face starting to go down.
Anaphylaxis-cardiovascular collapse 15 minutes after influenzae vaccine. Medical record states crying, cough, pale, limp, lethargic and loss of consciousness. msv
Headache, Sedation, Myalgia, NauseaVomiting, Chills Narrative: On the evening of 1/20/1 (day of injection) had injection site pain and some fatigue. Awoke on 1/21/21 with shaking /chills, nausea, severe headache and myalgias. Noted chills lasted until 10 am that day. Had headache and severe myalgias all day 1/21/21. No fever. Missed work x 1 day. No known prior COVID infection.
During injection patient jumped and moved, stating that it felt like a nerve was hit.    Afterwards said she felt okay.
Metallic taste was reported ten minutes after vaccination. Staff reported the reaction was fleeting (seconds long).  Patient  reported eating dehydrated strawberries just prior to vaccination but not sure if reaction was food related or vaccine related. Onsite MD assessed patient. No angioedema, respiratory distress, or any other complaints. Staff reported being back to baseline quickly after fleeting metallic taste.
Pt began developing small pustules on the right side of the neck, chest and behind the right ear around 6:00 PM the day he recieved the smallpox vaccine. The pustules behind the right ear grew larger and the pustules on the neck and chest were about 1/2 centimeter in clusters. Pt is being evaluated at the facility.
patient bad a negative pregnancy test on 3/3/2020 and was administered VARN AX on 3/3/2020; This spontaneous report was received from a registered nurse referring to a currently 39-year old female patient. The patient had no pertinent medical history, drug reactions/allergies and concomitant medication.  On 03-MAR-2020, the patient had a negative pregnancy test and was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (intramuscular, lot # S002084, expiration date was reported as 22-JUL-2021, but upon internal validation established as 21-JAN-2021; dose were unknown) for prophylaxis. The reporter did not know if the varicella virus vaccine live (oka/merck) (VARIVAX) administered on 03-MAR-2020 was the patient's first dose. Other suspect therapies included sterile diluent (STERILE DILUENT).    On 26-MAR-2020, the patient took an unspecified type of pregnancy test and the test was positive for pregnancy (vaccine exposure during pregnancy). The last menstrual period (LMP) was estimated to be 12-MAR-2020 and the estimated date of delivery (EDD) was 17-DEC-2020. The pregnancy outcome was pending. The fetal outcome was unknown.
pt hx of allergies/medications -- 30 min after injection, redness flushed face, cheeks and forehead, slight swelling on left side face- tingling. Injection site soreness. Benadryl 25mg dose. 1/11/2021 symptoms have resolved
No adverse effects. Per Director of Pharmacy Services at out clininc a report needed to be made due to error. Patient was administered the Pfizer vaccine monovalent for the incorrect age group. Pt is 2.5 yeals old and received the Pfizer monovalent vaccine of  for age group 5 yrs to 11 yrs old.
High blood pressure, palpitations, agitation, headache, feeling of lump in throat. Protonix 40mg tab. only one dose
No side effects reported/ No additional adverse events reported; Patient was given Proquad today instead of MMR; Patient was given Proquad today instead of MMR; This spontaneous report was received from a licensed practical nurse, referring to a 50-year-old patient of an unknown gender. Information regarding the patient's historical conditions, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.  On 19-APR-2021, the patient was intending to get a measles, mumps, and rubella (manufacturer unknown) booster dose; however, the patient was given a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) for prophylaxis (lot # T027294 was determined to be valid, expiration date reported and validated as 08-FEB-2021) (frequency scheme, route of administration and anatomical injection site were not reported) instead (wrong product administered and product administered to patient of inappropriate age). No side effects reported. No additional adverse events reported.
lymph nodes in left  side of neck, total 6 big and small nodes.; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0188) via an unspecified route of administration in the left arm on 21May2021 at 14:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any medication within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0171) via an unspecified route of administration in the right arm on 30Apr2021 at 14:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 30Jun2021, the patient underwent test with COVID-19 test (nasal swab) and the result was negative. On 13Jul2021 at 18:15, the patient experienced lymph nodes in left side of neck, total 6 big and small nodes. The event resulted in doctor or other healthcare professional office/clinic visit ,emergency room/department or urgent care . On an unknown date in 2021 patient underwent biopsy, unspecified blood test, (CT) examination and results were unknown. The clinical outcome of the event enlargement of lymph nodes was not recovered.
About 9 am, April 14, after breakfast, some fatigue and dizziness, a feeling  of nausea, then tingling in face, then numbness, followed by numbness in left arm, and finally numbness in leg.  Whole episode was probably about an hour. Numbness on left side lasted maybe 20 minutes, possibly more. (The day before-April 13 -- I had tingling in the face and arm but it resolved almost immediately, also after breakfast.)   Numbness of left arm returned for about 10 minutes that night while in hospital, but resolved except for remaining tingling in left hand.
No Adverse reactions patient fine and tolerated well.  Patient was given a TDAP and a Menveo  before it was due to give.  Mother was informed and aware.
He is not feeling well; Feels like he has been run down; Body aches and pains; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Lot number: EW0150) as dose 1, single for covid-19 immunisation. Relevant medical history included: "heart patient" (unspecified if ongoing), notes: he is a heart patient. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 15Apr2021, outcome "not recovered", described as "Feels like he has been run down"; PAIN (non-serious) with onset 15Apr2021, outcome "not recovered", described as "Body aches and pains"; MALAISE (non-serious), outcome "unknown", described as "He is not feeling well".  Additional Information: Consumer states that he had his first shot on 15Apr2021 of this month, it says it was Pfizer VCHD-delta EW0150. He does not know what VCHD- delta is they just gave him that card. He received the first dose of the Pfizer COVID vaccine. He has had effects from it. He has body aches and pains. He has not had fever; he has not had cough or shortness of breath, but he feels like he has been run down all the time. He is leery of having another shot so he might cancel the next shot and see if this straightens out. He says it depends on how long the report is. He guesses he is going to have to call the health department and tell them he is not going to come. He did not make an appointment, the made the appointment for him. He is not going, he already talked to his doctor and told him he is not feeling well but he had none of the other symptoms like shortness of breath or fever or coughing.   No follow-up attempts are possible. No further information is expected.
pt had a positive COVID test on 12/21/21; per death certificate and records, pt died in the nursing home; the causes of death were COVID 19 Pneumonia and Late-onset Alzheimer's Dementia
Patient was administrated with an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 47-year-old male patient who received HBV (Engerix B) (batch number 239tf, expiry date 6th June 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 20th June 2022, the patient received Engerix B and Engerix B Pre-Filled Syringe Device. On 20th June 2022, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 21-Jun-2022 Reporter's Comments: The reporter stated that the patient was administered with an expired dose of Engerix-B on 20th June 2022. The vaccine was expired on 06th June 2022. No adverse event was reported. The reporter consented to follow up. Additional Supportive Information: The patient was administered an expired dose of Engerix-B, which led to expired vaccine used.
Information has been received from a registered nurse regarding an unknown age and gender patient. On 03-MAR-2012 at 11:30am, ZOSTAVAX, lot # 672477/1604AA was exposed to -12 C for an estimated total time out of range of 4 hours. On 17-APR-2012 at 7:30am, ZOSTAVAX, lot # 672477/1604AA was exposed to -12 C for an estimated total time out of range of 4 hours. On 06-JUN-2012, the patient was administered an out of range dose of ZOSTAVAX, lot# 672477/1604AA expiration date: 13-JAN-2013 (dose and route were not reported). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to a 11-year-old male patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 14-NOV-2022, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.